Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI

NCT05101018 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

FED

Sponsor class

Conditions

Osteoporosis
Spinal Cord Injuries

Interventions

DRUG: Romosozumab
DRUG: Denosumab

Sponsor

James J. Peters Veterans Affairs Medical Center

Collaborators

[object Object]